世界各国のリアルタイムなデータ・インテリジェンスで皆様をお手伝い

世界および中国の腎性貧血治療市場の洞察、2027年までの予測

Global and China Renal Anemia Treatment Market Insights, Forecast to 2027

貧血はCKDの一般的な合併症であり、通常、発症初期に発生し、CKDの進行とともに重症化していきます。腎性貧血の主な治療目標は、ヘモグロビンおよびフェリチンなどの貧血パラメータを増加・維持することです。 ... もっと見る

出版社	出版年月	電子版価格	納期	言語
QYResearch QYリサーチ	2021年10月22日	US$3,900 シングルユーザライセンスライセンス・価格情報注文方法はこちら	5-7営業日	英語

※当ページの内容はウェブ更新時の情報です。
最新版の価格やページ数などの情報についてはお問合せください。
日本語のページは自動翻訳を利用し作成しています。
実際のレポートは英文のみでご納品いたします。

サマリー

貧血はCKDの一般的な合併症であり、通常、発症初期に発生し、CKDの進行とともに重症化していきます。腎性貧血の主な治療目標は、ヘモグロビンおよびフェリチンなどの貧血パラメータを増加・維持することです。

市場分析と洞察。世界および中国の腎性貧血治療市場
当レポートでは、世界および中国の腎性貧血治療薬市場に焦点を当てています。
2020年の世界の腎性貧血治療の市場規模はXX百万米ドルで、2021年から2027年の間にXX％のCAGRで、2027年末にはXX百万米ドルに達すると予想されています。中国では、腎性貧血治療の市場規模は、2020年のXX百万米ドルから2027年にはXX百万米ドルまで、予測期間中にXX％のCAGRで成長すると予想されています。

世界の腎性貧血治療の範囲と市場規模
腎性貧血治療薬市場は、地域（国）別、プレイヤー別、タイプ別、アプリケーション別に分類されています。世界の腎性貧血治療市場に参加するプレイヤー、ステークホルダー、その他の参加者は、本レポートを強力なリソースとして活用することで、優位に立つことができるでしょう。セグメント分析では、2016年から2027年までの地域（国）別、タイプ別、アプリケーション別の収益と予測に焦点を当てています。
中国市場については、2016年から2027年の期間で、プレーヤー別の腎性貧血治療の市場規模、、、、に焦点を当てています。主要プレイヤーには、中国で重要な役割を果たしているグローバルプレイヤーとローカルプレイヤーが含まれています。

セグメント
鉄分補給剤
赤血球増加剤（Erythrocyte Stimulating Agents

セグメント
病院
薬局
研究機関
その他

地域別
北アメリカ
アメリカ
カナダ
メキシコ
ヨーロッパ
ドイツ
フランス
イギリス
イタリア
ロシア
アジアパシフィック
中国
日本
韓国
インド
オーストラリア
台湾
インドネシア
タイ
マレーシア
フィリピン
ベトナム
ラテンアメリカ
メキシコ
ブラジル
アルゼンチン
中近東・アフリカ
トルコ
サウジアラビア
U.A.E.

会社別
Amgen Inc.
F. ホフマン・ラ・ロシュ社
ファイザー社
ノバルティス社
ジョンソン・エンド・ジョンソン・サービス株式会社
テバ・ファーマシューティカル・インダストリーズ・リミテッド
AMAGファーマシューティカルズ
ロックウェルメディカル
Akebia Therapeutics
Vifor Pharma Management Ltd.

ページTOPに戻る

1 Study Coverage
1.1 Renal Anemia Treatment Product Introduction
1.2 Market
1.2.1 Global Renal Anemia Treatment Market Size Growth Rate
1.2.2 Iron Supplements
1.2.3 Erythrocyte Stimulating Agents
1.3 Market
1.3.1 Global Renal Anemia Treatment Market Size Growth Rate
1.3.2 Hospital
1.3.3 Pharmacy
1.3.4 Research Institute
1.3.5 Other
1.4 Study Objectives
1.5 Years Considered

2 Executive Summary
2.1 Global Renal Anemia Treatment Market Size, Estimates and Forecasts
2.1.1 Global Renal Anemia Treatment Revenue 2016-2027
2.1.2 Global Renal Anemia Treatment Sales 2016-2027
2.2 Global Renal Anemia Treatment, Market Size by Region: 2016 VS 2021 VS 2027
2.3 Renal Anemia Treatment Historical Market Size by Region (2016-2021)
2.3.1 Global Renal Anemia Treatment Retrospective Market Scenario in Sales by Region: 2016-2021
2.3.2 Global Renal Anemia Treatment Retrospective Market Scenario in Revenue by Region: 2016-2021
2.4 Renal Anemia Treatment Market Estimates and Projections by Region (2022-2027)
2.4.1 Global Renal Anemia Treatment Sales Forecast by Region (2022-2027)
2.4.2 Global Renal Anemia Treatment Revenue Forecast by Region (2022-2027)

3 Global Renal Anemia Treatment Competitor Landscape by Players
3.1 Global Top Renal Anemia Treatment Manufacturers by Sales
3.1.1 Global Renal Anemia Treatment Sales by Manufacturer (2016-2021)
3.1.2 Global Renal Anemia Treatment Sales Market Share by Manufacturer (2016-2021)
3.2 Global Top Renal Anemia Treatment Manufacturers by Revenue
3.2.1 Key Renal Anemia Treatment Manufacturers Covered: Ranking by Revenue
3.2.2 Global Renal Anemia Treatment Revenue by Manufacturers (2016-2021)
3.2.3 Global Renal Anemia Treatment Revenue Share by Manufacturers (2016-2021)
3.2.4 Global Renal Anemia Treatment Market Concentration Ratio (CR5 and HHI) (2016-2021)
3.2.5 Global Top 10 and Top 5 Companies by Renal Anemia Treatment Revenue in 2020
3.2.6 Global Renal Anemia Treatment Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Global Renal Anemia Treatment Price by Manufacturers
3.4 Global Renal Anemia Treatment Manufacturing Base Distribution, Product Types
3.4.1 Renal Anemia Treatment Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Renal Anemia Treatment Product Type
3.4.3 Date of International Manufacturers Enter into Renal Anemia Treatment Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans

4 Breakdown Data (2016-2027)
4.1 Global Renal Anemia Treatment Market Size (2016-2021)
4.1.1 Global Renal Anemia Treatment Sales (2016-2021)
4.1.2 Global Renal Anemia Treatment Revenue (2016-2021)
4.1.3 Renal Anemia Treatment Average Selling Price (ASP) (2016-2021)
4.2 Global Renal Anemia Treatment Market Size Forecast (2022-2027)
4.2.1 Global Renal Anemia Treatment Sales Forecast (2022-2027)
4.2.2 Global Renal Anemia Treatment Revenue Forecast (2022-2027)
4.2.3 Renal Anemia Treatment Average Selling Price (ASP) Forecast (2022-2027)

5 Breakdown Data (2016-2027)
5.1 Global Renal Anemia Treatment Market Size (2016-2021)
5.1.1 Global Renal Anemia Treatment Sales (2016-2021)
5.1.2 Global Renal Anemia Treatment Revenue (2016-2021)
5.1.3 Renal Anemia Treatment Price (2016-2021)
5.2 Renal Anemia Treatment Market Size Forecast (2022-2027)
5.2.1 Global Renal Anemia Treatment Sales Forecast (2022-2027)
5.2.2 Global Renal Anemia Treatment Revenue Forecast (2022-2027)
5.2.3 Global Renal Anemia Treatment Price Forecast (2022-2027)

6 China by Players, and
6.1 China Renal Anemia Treatment Market Size YoY Growth 2016-2027
6.1.1 China Renal Anemia Treatment Sales YoY Growth 2016-2027
6.1.2 China Renal Anemia Treatment Revenue YoY Growth 2016-2027
6.1.3 China Renal Anemia Treatment Market Share in Global Market 2016-2027
6.2 China Renal Anemia Treatment Market Size by Players (International and Local Players)
6.2.1 China Top Renal Anemia Treatment Players by Sales (2016-2021)
6.2.2 China Top Renal Anemia Treatment Players by Revenue (2016-2021)
6.3 China Renal Anemia Treatment Historic Market Review (2016-2021)
6.3.1 China Renal Anemia Treatment Sales Market Share (2016-2021)
6.3.2 China Renal Anemia Treatment Revenue Market Share (2016-2021)
6.3.3 China Renal Anemia Treatment Price (2016-2021)
6.4 China Renal Anemia Treatment Market Estimates and Forecasts (2022-2027)
6.4.1 China Renal Anemia Treatment Sales Forecast (2022-2027)
6.4.2 China Renal Anemia Treatment Revenue Forecast (2022-2027)
6.4.3 China Renal Anemia Treatment Price Forecast (2022-2027)
6.5 China Renal Anemia Treatment Historic Market Review (2016-2021)
6.5.1 China Renal Anemia Treatment Sales Market Share (2016-2021)
6.5.2 China Renal Anemia Treatment Revenue Market Share (2016-2021)
6.5.3 China Renal Anemia Treatment Price (2016-2021)
6.6 China Renal Anemia Treatment Market Estimates and Forecasts (2022-2027)
6.6.1 China Renal Anemia Treatment Sales Forecast (2022-2027)
6.6.2 China Renal Anemia Treatment Revenue Forecast (2022-2027)
6.6.3 China Renal Anemia Treatment Price Forecast (2022-2027)

7 North America
7.1 North America Renal Anemia Treatment Market Size YoY Growth 2016-2027
7.2 North America Renal Anemia Treatment Market Facts & Figures by Country
7.2.1 North America Renal Anemia Treatment Sales by Country (2016-2021)
7.2.2 North America Renal Anemia Treatment Revenue by Country (2016-2021)
7.2.3 United States
7.2.4 Canada
7.2.5 Mexico

8 Asia Pacific
8.1 Asia Pacific Renal Anemia Treatment Market Size YoY Growth 2016-2027
8.2 Asia Pacific Renal Anemia Treatment Market Facts & Figures by Region
8.2.1 Asia Pacific Renal Anemia Treatment Sales by Region (2016-2021)
8.2.2 Asia Pacific Renal Anemia Treatment Revenue by Region (2016-2021)
8.2.3 China
8.2.4 Japan
8.2.5 South Korea
8.2.6 India
8.2.7 Australia
8.2.8 Australia
8.2.9 Indonesia
8.2.10 Thailand
8.2.11 Malaysia
8.2.12 Philippines
8.2.13 Vietnam

9 Europe
9.1 Europe Renal Anemia Treatment Market Size YoY Growth 2016-2027
9.2 Europe Renal Anemia Treatment Market Facts & Figures by Country
9.2.1 Europe Renal Anemia Treatment Sales by Country (2016-2021)
9.2.2 Europe Renal Anemia Treatment Revenue by Country (2016-2021)
9.2.3 Germany
9.2.4 France
9.2.5 U.K.
9.2.6 Italy

10 Latin America
10.1 Latin America Renal Anemia Treatment Market Size YoY Growth 2016-2027
10.2 Latin America Renal Anemia Treatment Market Facts & Figures by Country
10.2.1 Latin America Renal Anemia Treatment Sales by Country (2016-2021)
10.2.2 Latin America Renal Anemia Treatment Revenue by Country (2016-2021)
10.2.3 Mexico
10.2.4 Brazil
10.2.5 Argentina

11 Middle East and Africa
11.1 Middle East and Africa Renal Anemia Treatment Market Size YoY Growth 2016-2027
11.2 Middle East and Africa Renal Anemia Treatment Market Facts & Figures by Country
11.2.1 Middle East and Africa Renal Anemia Treatment Sales by Country (2016-2021)
11.2.2 Middle East and Africa Renal Anemia Treatment Revenue by Country (2016-2021)
11.2.3 Turkey
11.2.4 Saudi Arabia
11.2.5 U.A.E

12 Company Profiles
12.1 Amgen Inc.
12.1.1 Amgen Inc. Corporation Information
12.1.2 Amgen Inc. Description and Business Overview
12.1.3 Amgen Inc. Renal Anemia Treatment Sales, Revenue and Gross Margin (2016-2021)
12.1.4 Amgen Inc. Renal Anemia Treatment Products Offered
12.1.5 Amgen Inc. Recent Development
12.2 F. Hoffmann-La Roche Ltd
12.2.1 F. Hoffmann-La Roche Ltd Corporation Information
12.2.2 F. Hoffmann-La Roche Ltd Description and Business Overview
12.2.3 F. Hoffmann-La Roche Ltd Renal Anemia Treatment Sales, Revenue and Gross Margin (2016-2021)
12.2.4 F. Hoffmann-La Roche Ltd Renal Anemia Treatment Products Offered
12.2.5 F. Hoffmann-La Roche Ltd Recent Development
12.3 Pfizer Inc.
12.3.1 Pfizer Inc. Corporation Information
12.3.2 Pfizer Inc. Description and Business Overview
12.3.3 Pfizer Inc. Renal Anemia Treatment Sales, Revenue and Gross Margin (2016-2021)
12.3.4 Pfizer Inc. Renal Anemia Treatment Products Offered
12.3.5 Pfizer Inc. Recent Development
12.4 Novartis AG
12.4.1 Novartis AG Corporation Information
12.4.2 Novartis AG Description and Business Overview
12.4.3 Novartis AG Renal Anemia Treatment Sales, Revenue and Gross Margin (2016-2021)
12.4.4 Novartis AG Renal Anemia Treatment Products Offered
12.4.5 Novartis AG Recent Development
12.5 Johnson & Johnson Services Inc.
12.5.1 Johnson & Johnson Services Inc. Corporation Information
12.5.2 Johnson & Johnson Services Inc. Description and Business Overview
12.5.3 Johnson & Johnson Services Inc. Renal Anemia Treatment Sales, Revenue and Gross Margin (2016-2021)
12.5.4 Johnson & Johnson Services Inc. Renal Anemia Treatment Products Offered
12.5.5 Johnson & Johnson Services Inc. Recent Development
12.6 Teva Pharmaceutical Industries Ltd.
12.6.1 Teva Pharmaceutical Industries Ltd. Corporation Information
12.6.2 Teva Pharmaceutical Industries Ltd. Description and Business Overview
12.6.3 Teva Pharmaceutical Industries Ltd. Renal Anemia Treatment Sales, Revenue and Gross Margin (2016-2021)
12.6.4 Teva Pharmaceutical Industries Ltd. Renal Anemia Treatment Products Offered
12.6.5 Teva Pharmaceutical Industries Ltd. Recent Development
12.7 AMAG Pharmaceuticals
12.7.1 AMAG Pharmaceuticals Corporation Information
12.7.2 AMAG Pharmaceuticals Description and Business Overview
12.7.3 AMAG Pharmaceuticals Renal Anemia Treatment Sales, Revenue and Gross Margin (2016-2021)
12.7.4 AMAG Pharmaceuticals Renal Anemia Treatment Products Offered
12.7.5 AMAG Pharmaceuticals Recent Development
12.8 Rockwell Medical
12.8.1 Rockwell Medical Corporation Information
12.8.2 Rockwell Medical Description and Business Overview
12.8.3 Rockwell Medical Renal Anemia Treatment Sales, Revenue and Gross Margin (2016-2021)
12.8.4 Rockwell Medical Renal Anemia Treatment Products Offered
12.8.5 Rockwell Medical Recent Development
12.9 Akebia Therapeutics
12.9.1 Akebia Therapeutics Corporation Information
12.9.2 Akebia Therapeutics Description and Business Overview
12.9.3 Akebia Therapeutics Renal Anemia Treatment Sales, Revenue and Gross Margin (2016-2021)
12.9.4 Akebia Therapeutics Renal Anemia Treatment Products Offered
12.9.5 Akebia Therapeutics Recent Development
12.10 Vifor Pharma Management Ltd.
12.10.1 Vifor Pharma Management Ltd. Corporation Information
12.10.2 Vifor Pharma Management Ltd. Description and Business Overview
12.10.3 Vifor Pharma Management Ltd. Renal Anemia Treatment Sales, Revenue and Gross Margin (2016-2021)
12.10.4 Vifor Pharma Management Ltd. Renal Anemia Treatment Products Offered
12.10.5 Vifor Pharma Management Ltd. Recent Development
12.11 Amgen Inc.
12.11.1 Amgen Inc. Corporation Information
12.11.2 Amgen Inc. Description and Business Overview
12.11.3 Amgen Inc. Renal Anemia Treatment Sales, Revenue and Gross Margin (2016-2021)
12.11.4 Amgen Inc. Renal Anemia Treatment Products Offered
12.11.5 Amgen Inc. Recent Development

13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
13.1 Renal Anemia Treatment Industry Trends
13.2 Renal Anemia Treatment Market Drivers
13.3 Renal Anemia Treatment Market Challenges
13.4 Renal Anemia Treatment Market Restraints

14 Value Chain and Sales Channels Analysis
14.1 Value Chain Analysis
14.2 Renal Anemia Treatment Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors

15 Research Findings and Conclusion

16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
16.3 Disclaimer

ページTOPに戻る

Table of Contents

Summary

Anemia is a common complication of CKD, typically occurring early in the development of the disease and becoming more severe as CKD progresses. The primary treatment goal in renal anemia is to increase and maintain hemoglobin and other anemia parameters, such as ferritin.

Market Analysis and Insights: Global and China Renal Anemia Treatment Market
This report focuses on global and China Renal Anemia Treatment market.
In 2020, the global Renal Anemia Treatment market size was US$ XX million and it is expected to reach US$ XX million by the end of 2027, with a CAGR of XX% during 2021-2027. In China the Renal Anemia Treatment market size is expected to grow from US$ XX million in 2020 to US$ XX million by 2027, at a CAGR of XX% during the forecast period.

Global Renal Anemia Treatment Scope and Market Size
Renal Anemia Treatment market is segmented by region (country), players, by Type, and by Application. Players, stakeholders, and other participants in the global Renal Anemia Treatment market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by region (country), by Type and by Application in terms of revenue and forecast for the period 2016-2027.
For China market, this report focuses on the Renal Anemia Treatment market size by players, , and , for the period 2016-2027. The key players include the global and local players which play important roles in China.

Segment
Iron Supplements
Erythrocyte Stimulating Agents

Segment
Hospital
Pharmacy
Research Institute
Other

By Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E

By Company
Amgen Inc.
F. Hoffmann-La Roche Ltd
Pfizer Inc.
Novartis AG
Johnson & Johnson Services Inc.
Teva Pharmaceutical Industries Ltd.
AMAG Pharmaceuticals
Rockwell Medical
Akebia Therapeutics
Vifor Pharma Management Ltd.

ページTOPに戻る

ご注文は、お電話またはWEBから承ります。お見積もりの作成もお気軽にご相談ください。

webからのご注文・お問合せはこちらのフォームから承ります

本レポートと同分野の最新刊レポート

本レポートと同分野の最新刊レポートはありません。

QYResearch社の
Fatal error: Uncaught TypeError: Cannot access offset of type string on string in /var/www/vhosts/dri.co.jp/httpdocs/PHPLibs/Smarty/templates_c/58b4bde6a9738f3389cd7dea7f4ef5c62fdc6c54_0.file.auto_report.tpl.php:630 Stack trace: #0 /var/www/vhosts/dri.co.jp/httpdocs/PHPLibs/Smarty/libs/sysplugins/smarty_template_resource_base.php(123): content_68d51da90169e8_18903235() #1 /var/www/vhosts/dri.co.jp/httpdocs/PHPLibs/Smarty/libs/sysplugins/smarty_template_compiled.php(114): Smarty_Template_Resource_Base->getRenderedTemplateCode() #2 /var/www/vhosts/dri.co.jp/httpdocs/PHPLibs/Smarty/libs/sysplugins/smarty_internal_template.php(216): Smarty_Template_Compiled->render() #3 /var/www/vhosts/dri.co.jp/httpdocs/PHPLibs/Smarty/libs/sysplugins/smarty_internal_template.php(385): Smarty_Internal_Template->render() #4 /var/www/vhosts/dri.co.jp/httpdocs/PHPLibs/Smarty/templates_c/f20300271f4eb0fb4a2cf788aaabb06be5646d19_0.file.frame-FULL.tpl.php(278): Smarty_Internal_Template->_subTemplateRender() #5 /var/www/vhosts/dri.co.jp/httpdocs/PHPLibs/Smarty/libs/sysplugins/smarty_template_resource_base.php(123): content_68b0f61a4d9868_07068969() #6 /var/www/vhosts/dri.co.jp/httpdocs/PHPLibs/Smarty/libs/sysplugins/smarty_template_compiled.php(114): Smarty_Template_Resource_Base->getRenderedTemplateCode() #7 /var/www/vhosts/dri.co.jp/httpdocs/PHPLibs/Smarty/libs/sysplugins/smarty_internal_template.php(216): Smarty_Template_Compiled->render() #8 /var/www/vhosts/dri.co.jp/httpdocs/PHPLibs/Smarty/libs/sysplugins/smarty_internal_templatebase.php(238): Smarty_Internal_Template->render() #9 /var/www/vhosts/dri.co.jp/httpdocs/PHPLibs/Smarty/libs/sysplugins/smarty_internal_templatebase.php(134): Smarty_Internal_TemplateBase->_execute() #10 /var/www/vhosts/dri.co.jp/httpdocs/auto/show_report.php(776): Smarty_Internal_TemplateBase->display() #11 {main} thrown in /var/www/vhosts/dri.co.jp/httpdocs/PHPLibs/Smarty/templates_c/58b4bde6a9738f3389cd7dea7f4ef5c62fdc6c54_0.file.auto_report.tpl.php on line 630

世界および中国の腎性貧血治療市場の洞察、2027年までの予測

サマリー

目次

Summary

Table of Contents

ご注文は、お電話またはWEBから承ります。お見積もりの作成もお気軽にご相談ください。

本レポートと同分野の最新刊レポート